Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELRANATAMAB vs EMICIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELRANATAMAB vs EMICIZUMAB: Safety Overview

Metric ELRANATAMAB EMICIZUMAB
Total FAERS Reports 758 733
Deaths Reported 177 42
Death Rate 23.4% 5.7%
Hospitalizations 482 159
Average Patient Age 67.6 yrs 30.7 yrs
% Female Patients 45.2% 7.1%
Manufacturer Pfizer Laboratories Div Pfizer Inc Genentech, Inc.
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status Prescription Prescription